FDA Approves New Prescription Weight Loss DrugSt Louis, MO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Food and Drug Administration has granted approval for Zepbound™, an innovative weight loss medication developed by Eli Lilly. In clinical trials, this groundbreaking drug demonstrated the potential to help individuals shed up to 52 pounds within a 16-month timeframe. The active ingredient in Zepbound is tirzepatide, which is the same... ❯❯❯
MARKHAM, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2023. Results are presented in Canadian dollars unless otherwise noted. Third Quarter Highlights Home health care volume growth continued, with Q3 average daily volume (“ADV”) of 27,378, an increase of 1.0% from Q2 2023 and 9.3% from Q3 2022.Long-ter... ❯❯❯
MARKHAM, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three and nine months ended September 30, 2023. The Consolidated Financial Statements and accompanying Management’s Discussion and Analysis (“MD&A”) are available on the Company’s website at www.siennaliving.ca and on SEDAR at www.sedar.com. Sienna’s strong year over year... ❯❯❯
SAN DIEGO, California, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced today the execution of an exclusive license agreement. Exagen will focus on the development of novel patented biomarkers for therapeutic management of patients with lupus nephritis. Under the terms of the license agreement, Exagen will acquire a... ❯❯❯
Toronto, Ontario, Nov. 08, 2023 (GLOBE NEWSWIRE) -- LifeLabs is honoured to have welcomed the Honourable Doug Ford, Premier of Ontario, to our state-of-the-art medical diagnostic laboratory. Today's visit marks an important recognition of our long-lasting partnership with the Ontario government, emphasizing our shared commitment to advancing the healthcare and well-being of Ontarians. LifeLabs has dedicated the past three years to... ❯❯❯
Consolidated Revenue increased 14.8% to $402.0 million in the third quarter of 2023 from $350.0 million in the third quarter of 2022; Excluding Revenue from our Artificial Intelligence (“AI”) reporting segment, Revenue from the Imaging Centers reporting segment in the third quarter of 2023 was $399.1 million, an increase of 14.3% from last year’s third quarter of $349.1 millionExcluding losses from our AI reporting segment, Adjusted... ❯❯❯
LINCOLN, Neb., Nov. 07, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2023. Regarding the Company’s 2023 third quarter, Kevin Karas, Chief Financial Officer, said, “New sales increased compared to the third quarter of 2022, supported by growth in our Human Understanding Program, with adoption by 91 healthcare organizations as of September 30, 2023.... ❯❯❯
Conference Call and Webcast scheduled for tomorrow, November 8, 2023 at 10:00 am MTEAGLE, Idaho, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the third quarter of 2023, reporting GAAP diluted earnings per share of $0.15 and adjusted diluted earnings per share of... ❯❯❯
BANNOCKBURN, Ill., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference, being held in London, on Tuesday, November 14, 2023, including a fireside chat at 10:30am GMT/5:30am ET.Bank of... ❯❯❯
Through early detection, many cases of prediabetes and Type 2 diabetes are reversible with the help of healthy lifestyle adjustments.Toronto, Ontario, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LifeLabs is pleased to announce its partnership with LifestyleRx to offer Canadians greater support in managing their health with prediabetes and Type 2 diabetes. Canada has a growing diabetes population with currently 1 in 3 Canadians living with... ❯❯❯